Pharmathen SA, based in Amstelveen, Netherlands, is a private pharmaceutical company that develops and markets generic drugs.
Based in Amstelveen, Netherlands, Pharmathen SA was founded in 1969 by the pharmacist Nikolaos Katsos. The private company develops, produces and markets generic drugs and active pharmaceutical ingredients, including long-acting injectables and modified release oral formulations. In July 2021, Partners Group agreed to acquire Pharmathen Global BV from BC Partners at an enterprise value of approximately EUR 1.6 billion. The company generated EUR 16.44 million in revenue in 2020 and is at the Late stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in